Cardioprotective efficacy of combined therapy with azilsartan, indapamide, and nitrendipine in patients with essential hypertension

Back

ESC Professional Premium Access

Cardioprotective efficacy of combined therapy with azilsartan, indapamide, and nitrendipine in patients with essential hypertension

Session: Hypertension target organ damage

Topic: Pharmacotherapy

Speaker: Assistant Professor Z. Mashkurova (Tashkent, UZ)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Assistant Professor Zaringiz Mashkurova

Republican Specialized Scientific Practical Medical Center Of Cardiology, Tashkent (Uzbekistan)

1 follower

8 more presentations in this session

Orthostatic blood pressure changes and incident atrial fibrillation in patients with hypertension: Insights from the SPRINT trial

Speaker: Doctor J. Wang (Beijing, CN)

Diagnostic and prognostic value of ECG-predicted hypertension mediated left ventricular hypertrophy using machine learning

Speaker: Doctor H. Naderi (London, GB)

Carotid-Femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes

Speaker: Doctor A. Maloberti (Milan, IT)

Cardiac magnetic resonance (CMR) height-based allometric scaling in Southeast Asians; implications in the diagnosis and prognosis of left ventricular hypertrophy (LVH): the REMODEL study

Speaker: Mr C. Lee (Dundee, GB)

Relationship between renin, aldosterone, aldosterone-to-renin ratio and left ventricular mass index in young adults

Speaker: Doctor R. Ananda (Melbourne, AU)

Access the full session

Hypertension target organ damage

Speakers: Assistant Professor Z. Mashkurova, Doctor J. Wang, Doctor H. Naderi, Doctor A. Maloberti, Mr C. Lee...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources